Metronomic chemotherapy, dampening of immunosuppressive cells, antigen presenting cell activation, and T cells. A quartet against refractoriness and resistance to checkpoint inhibitors
Giulia Bravetti, Paolo Falvo, Giovanna Talarico, Stefania Orecchioni, Francesco Bertolini
Topics & Concepts
Immune systemImmunologyMedicineAntigenCancer researchClinical trialPharmacologyCancer cellT cellImmunotherapyChemotherapyCancerInternal medicineCAR-T cell therapy researchImmune Cell Function and InteractionCancer Immunotherapy and Biomarkers